Staring at a woman for over 14 seconds can land you in jail: Kerala official

New Delhi, Jun 25: The Central government submitted before the Supreme Court on Thursday that the remaining class 10 and 12 CBSE exams, which were earlier rescheduled to be held between July 1 to July 15 in view of the COVID-19 pandemic, have been cancelled.

Solicitor General Tushar Mehta, appearing for the Centre and Central Board of Secondary Education (CBSE), informed a three-judge bench headed by Justice AM Khanwilkar that the remaining class 10 and 12 CBSE exams scheduled to be held in July have been cancelled.

Delhi, Maharashtra, and Tamil Nadu have conveyed their inability to conduct the examinations, Mehta said.

The bench asked whether class 12 students were being given the option to either get marks on the internal assessment basis or appear for an exam later, to which the Mehta responded in the affirmative.

CBSE exams for class 10 students stand cancelled, Mehta said and added that they don't have to give any examinations. Mehta further submitted that as soon as conditions are conducive, CBSE exams for class 12 students, who opt for it, will be conducted.

The apex court was hearing a petition, filed by advocate Rishi Malhotra, seeking directions to cancel the remaining CBSE exams in view of the health risk of coronavirus infection. The apex court was also hearing a similar petition regarding the ICSE exams.

Indian Certificate of Secondary Education (ICSE), through its counsel Jaideep Gupta, also informed the court that it will also cancel the class 10 and 12 board exams. However, it submitted that it does not agree to give the option to students to give the exam later.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.